Advertisement

Purine metabolism in normal and pathologic lymphoid cell differentiation

  • H. J. Schuurman
  • J. P. R. M. Van Laarhoven
  • G. C. De Gast
Chapter
  • 43 Downloads
Part of the Developments in Oncology book series (DION, volume 32)

Abstract

Intact purine metabolism is pivotal for proper functioning of (lymphoid) cells. During the generation of immunocompetent lymphocytes of T- or B-cell lineage, and during subsequent differentiation into effector cells, cell divisions occur which require DNA synthesis. Studies of the causal relationship between deficiency of certain purine nucleotide metabolizing enzymes and deficiencies in immune function, revealed several privileged pathways in purine metabolism (Fig. 1). These pathways are different for T- and B-cells in different stages of maturation, and are related to purine enzyme activities [1, 2]. Assessment of purine nucleotide metabolizing enzymes in lymphoreticular malignancies [3, 4] showed enzyme activities that could be related to normal lymphoid cell differentiation. In addition, the purine enzyme make-up of lymphoid cells may be applied in malignant cell typing and permits estimation of the effectiveness of enzyme-directed chemotherapy. This survey focuses on these different aspects.

Keywords

Ribonucleotide Reductase Purine Metabolism Purine Nucleotide Purine Nucleoside Phosphorylase dNTP Pool 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mitchell BS and Kelley WN (1980). Purinogenic immunodeficiency diseases: Clinical features and molecular mechanisms. Ann Intern Med 92: 826–831.PubMedGoogle Scholar
  2. 2.
    Watts RWE (1983). Purine enzymes and immune function. Clin Biochem 16: 48–53.PubMedCrossRefGoogle Scholar
  3. 3.
    Hoffbrand AV, Ma DDF and Webster ADB (1982). Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency syndromes. Clin Haematol 11: 719–741.PubMedGoogle Scholar
  4. 4.
    van Laarhoven JPRM and de Bruyn CHMM (1983). Purine metabolism in relation to leukemia and lymphoid cell differentiation. Leuk Res 7: 451–480.PubMedCrossRefGoogle Scholar
  5. 5.
    van Laarhoven JPRM, Spierenburg GTh, Collet H et al. (1984). Purine interconversion pathways in T, B, Ty and T-Ty-cells from human peripheral blood. Adv Exp Med Biol 165B: 111–118.PubMedGoogle Scholar
  6. 6.
    Ma DDF, Sylwestrowicz TA, Granger S et al. (1982). Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes. J Immunol 129: 1430–1435.PubMedGoogle Scholar
  7. 7.
    Massaia M, Ma DDF, Sylwestrowicz TA et al. (1982). Enzymes of purine metabolism in human peripheral lymphocyte subpopulations. Clin Exp Immunol 50: 148–154.PubMedGoogle Scholar
  8. 8.
    Müller-Hermelink HK (1974). Characterization of the B-cell and T-cell regions of human lymphatic tissue through histochemical demonstration of ATPase and 5’nucleotidase activities. Virchow Arch B Cell Pathol 16: 371–378.CrossRefGoogle Scholar
  9. 9.
    Cohen A, Lee JWW, Dosch H-M and Gelfand EW (1980). The expression of deoxyguanosine toxicity in T-lymphocytes at different stages of maturation. J Immunol 125, 1578–1582.PubMedGoogle Scholar
  10. 10.
    Schuurman HJ, van Laarhoven JPRM, Broekhuizen R et al. (1983). Lymphocyte maturation in the human thymus. Relevance of purine nucleotide metabolism for intrathymic T-cell function. Scand J Immunol 18: 539–549.PubMedCrossRefGoogle Scholar
  11. 11.
    Cohen A, Barankiewicz J, Lederman HM and Gelfand EW (1983). Purine and pyrimidine metabolism in human T-lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem 258: 12334–12340.PubMedGoogle Scholar
  12. 12.
    Carson DA and Wasson BD (1982). Characterization of an adenosine 5’-triphosphate-and deoxyadenosine 5’-triphosphate-activated nucleotidase from human malignant lymphocytes. Cancer Res 42: 4321–4324.PubMedGoogle Scholar
  13. 13.
    Spaapen LJM, Rijkers GT, Staal GEJ et al. (1984). The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the the interference with lymphocyte proliferation in vitro. J Immunol 132: 2311–2317.PubMedGoogle Scholar
  14. 14.
    Spaapen LJM, Rijkers GT, Staal GEJ et al. (1984). The effect of deoxyguanosine on human lymphocyte function. II. Analysis of the interference with B-lymphocyte differentiation in vitro. J Immunol 132: 2318–2323.PubMedGoogle Scholar
  15. 15.
    Hadden JW and Coffey RG (1982). Cyclic nucleotides in mitogen-induced lymphocyte proliferation. Immunol Today 3: 299–304.CrossRefGoogle Scholar
  16. 16.
    Ma DDF, Sylwestrowicz T, Janossy G and Hoflbrand AV (1983). The role of purine metabolic enzymes and terminal deoxynucleotidyl transferase in intrathymic T-cell differentiation. Immunol Today 4: 65–68.CrossRefGoogle Scholar
  17. 17.
    Baltimore D (1974). Is terminal deoxynucleotidyl transferase a somatic mutagen in lymphocytes? Nature 248: 409–411.PubMedCrossRefGoogle Scholar
  18. 18.
    Gearhart PJ (1982). Generation of immunoglobulin variable gene diversity. Immunol Today 3: 407–412.CrossRefGoogle Scholar
  19. 19.
    Ganeshaguru K, Lee N, Llewellin P et al. (1981). Adenosine deaminase concentrations in leukemia and lymphoma: Relation to cell phenotypes. Leuk Res 5: 215–222.PubMedCrossRefGoogle Scholar
  20. 20.
    Ma DDF, Massaia M, Sylwestrowicz TA et al. (1983). Comparison of purine degradative enzymes and terminal deoxynucleotidyl transferase in T-cell leukemias and in normal thymic and post-thymic T-cells. Brit J Haematol 54: 451–457.CrossRefGoogle Scholar
  21. 21.
    van Laarhoven JPRM, Spierenburg GTh, Bakkeren JAJM et al. (1983). Purine metabolism in childhood acute lymphoblastic leukemia: Biochemical markers for diagnosis and chemotherapy. Leuk Res 7: 407–420.PubMedCrossRefGoogle Scholar
  22. 22.
    van Laarhoven JPRM, de Gast GC, Spierenburg GTH and de Bruyn CHMM (1983). Enzymological studies in chronic lymphocytic leukemia. Leuk Res 7: 261–267.PubMedCrossRefGoogle Scholar
  23. 23.
    Blatt J, Bunn PA, Carney DD et al (1982). Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T-cell lymphoma. Brit J Haematol 52: 97–104.CrossRefGoogle Scholar
  24. 24.
    Demeocq F, Viallard JL, Boumsell L et al. (1982). The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignancies. Leuk Res 6: 211–220.PubMedCrossRefGoogle Scholar
  25. 25.
    Foon KA, Schroff RW and Gale RP (1982). Surface markers on leukemia and lymphoma cells: Recent advances. Blood 60: 1–19.PubMedGoogle Scholar
  26. 26.
    Schornagel JH (1982). Studies on the reversal of methotrexate toxicity by thymidine and on the role of thymidine as an anti-cancer drug. Thesis, Utrecht.Google Scholar
  27. 27.
    Howell SB, Teatle R and Mendelsohn J (1980). Thymidine as a chemotherapeutic agent: Sensitivity of normal human marrow, peripheral blood T-cells, and acute nonlymphocytic leukemia. Blood 55: 505–510.PubMedGoogle Scholar
  28. 28.
    Kufe DW, Beardsley P, Karp D et al. (1980). High dose thymidine infusions in patients with leukemia and lymphoma. Blood 55: 580–589.PubMedGoogle Scholar
  29. 29.
    Fox RM, Kefford RF, Tripp EH and Taylor IW (1981). G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine. Cancer Res 41: 5141–5150.PubMedGoogle Scholar
  30. 30.
    Carson DA, Kaye J and Wasson DB (1981). The potential importance of soluble deoxynucleotidase activity in mediating deoxyadenosine toxicity in human lymphoblasts. J Immunol 126: 348–352.PubMedGoogle Scholar
  31. 31.
    Fox RM, Piddington SK, Tripp EH and Tattersall MHN (1981). Ecto-adenosine triphosphate deficiency in cultured human T- and null-leukemic lymphocytes. J Clin Invest 68: 544–552.PubMedCrossRefGoogle Scholar
  32. 32.
    Kefford RF, Helmer MA and Fox RM (1982). S-adenosylhomocysteine hydrolase inhibition in deoxyadenosine-treated human T-lymphoblasts and resting peripheral blood lymphocytes. Cancer Res 42: 3822–3827.PubMedGoogle Scholar
  33. 33.
    Russel NH, Prentice HG, Lee N et al. (1981). Studies on the biochemical sequelae of therapy in Thy-1 acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2’deoxycoformycin. Brit J Haematol 49: 1–9.CrossRefGoogle Scholar
  34. 34.
    Bagnara AS and Hershfield MS (1982). Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T-lymphoblastoid cells. Proc Nat Acad Sci USA 79: 2673–2677.PubMedCrossRefGoogle Scholar
  35. 35.
    Matsumoto SS, Yu AL, Bleeker et al. (1982). Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin. Blood 60: 1096–1102.PubMedGoogle Scholar
  36. 36.
    Prentice HG, Russell NH, Lee N et al. (1981). Therapeutic selectivity of and prediction of response to 2’deoxycoformycin in acute leukemia. Lancet 2: 1250–1253.PubMedCrossRefGoogle Scholar
  37. 37.
    Sylwestrowicz T, Piga A, Murphy P et al. (1982). The effects of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells. Brit J Haematol 51: 623–630.CrossRefGoogle Scholar
  38. 38.
    Kazmers IS, Mitchell BS, Dadonna PE et al. (1981). Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: Selective toxicity for T-lymphoblasts. Science 214: 1137–1139.PubMedCrossRefGoogle Scholar
  39. 39.
    Rijkers GT, Zegers BJM, Spaapen LJM et al. (1984). Mononuclear cells in S-phase in a patient with purine nucleoside phosphorylase deficiency. Adv Exp Med Biol 165B: 171–174.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1985

Authors and Affiliations

  • H. J. Schuurman
    • 1
  • J. P. R. M. Van Laarhoven
    • 3
  • G. C. De Gast
    • 2
  1. 1.Division of ImmunopathologyUniversity HospitalUtrechtthe Netherlands
  2. 2.Division of ImmunohematologyUniversity HospitalUtrechtthe Netherlands
  3. 3.Department of Human GeneticsUniversity Hospital St. RadboudNijmegenthe Netherlands

Personalised recommendations